ACP

Acuta Capital Partners Portfolio holdings

AUM $147M
1-Year Est. Return 491.59%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+491.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$173M
AUM Growth
-$15M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$7.06M
2
+$6.04M
3
+$4.72M
4
IMMU
Immunomedics Inc
IMMU
+$3.51M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$3.2M

Top Sells

1
+$10.6M
2
+$4.78M
3
+$3.75M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$3.17M
5
TVTX icon
Travere Therapeutics
TVTX
+$2.58M

Sector Composition

1 Healthcare 71.32%
2 Technology 2.19%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$1.41M 0.81%
+165,368
27
$1.28M 0.74%
320,897
-886,829
28
$1.01M 0.59%
+232,800
29
$507K 0.29%
+10,341
30
$431K 0.25%
120,958
+2,455
31
$236K 0.14%
913
+62
32
$171K 0.1%
47,431
33
– –
-167,109
34
– –
-21,529
35
– –
-44,078
36
– –
0
37
– –
0
38
– –
-56,000
39
– –
-24,813
40
– –
0
41
– –
-16,877
42
– –
-1
43
– –
0
44
– –
-28,400
45
– –
0
46
– –
-27,952
47
– –
0
48
– –
-113,807
49
– –
0
50
– –
0
1
2
3